Author Archive: Jim Lane

rss feed

The Digest’s 2026 Multi-Slide Guide to Bioeconomy Workforce Bottlenecks

The Digest’s 2026 Multi-Slide Guide to Bioeconomy Workforce Bottlenecks

August 26, 2026 |

Vague national projections of one million bioindustrial jobs by 2030 are unhelpful demand hypotheses rather than measurements. Instead, the bioeconomy faces forty two highly specific occupational bottlenecks. For instance, critical roles like instrumentation and control technicians lack a single federal job code, complicating recruitment. Furthermore, location quotient analysis reveals that key occupations are highly regional […]

Read More

The Digest’s 2026 Multi-Slide Guide to Operator Competence and Commissioning

The Digest’s 2026 Multi-Slide Guide to Operator Competence and Commissioning

August 25, 2026 |

For novel bioprocesses, operator competence cannot exist beforehand because commissioning itself must first create it. While educational curricula transfer general procedures and hazard awareness, forty hours of training cannot teach judgment under abnormal operations, fault diagnosis, or recovery. To prevent operational knowledge gaps, developers must place operators in the room during commissioning, incurring the price […]

Read More

The Digest’s 2026 Multi-Slide Guide to EPC Capacity and Owner Teams

The Digest’s 2026 Multi-Slide Guide to EPC Capacity and Owner Teams

August 24, 2026 |

Developers often blame labor shortages for slipping schedules and rush to lock construction capacity. However, evidence shows that selective contractor bidding is a commercial risk posture, not a workforce shortage. The true bottleneck lies on the owner’s side of the table, where seventy three percent of capital project teams are understaffed or lack experienced leadership. […]

Read More

Why Good Projects Die: Part 2, From 302 Projects to Bankable Value

Why Good Projects Die: Part 2, From 302 Projects to Bankable Value

August 24, 2026 |

In Part 1, we followed six discoveries that changed the way we think about project failure. Failure proved to be a trajectory, not a condition. Problems interacted. Viable futures could be preserved. Sequence mattered. Those observations could be represented within a formal mathematical framework. And, perhaps most surprisingly, fewer than 5 percent of the failed […]

Read More

Why Good Projects Die, Part 1: 6 Things We Learned From 302 Bioeconomy Projects

Why Good Projects Die, Part 1: 6 Things We Learned From 302 Bioeconomy Projects

August 24, 2026 |

For years, we have watched promising bioeconomy projects disappear. Some had celebrated technologies. Some had strong management teams, blue-chip partners, government support, attractive markets and hundreds of millions of dollars of announced investment. Many had favorable techno-economic analyses. Many had technologies judged sufficiently mature to proceed. And yet they failed. Others, facing apparently formidable obstacles, […]

Read More

Unlocking 45Z: Why Your Tax Credit Depends on a Farmer’s Record

Unlocking 45Z: Why Your Tax Credit Depends on a Farmer’s Record

August 24, 2026 |

By Jayce Hafner, CEO, FarmRaise Special to The Digest I’m a farmer’s daughter, born and raised in the heart of the Shenandoah Valley, where I live today. As a kid, I helped my dad plant clover and get our steers to market. Working together, farmer neighbors traded stories of farm management: new tillage practices, beef […]

Read More

The Digest’s 2026 Multi-Slide Guide to Bioproduct Quality Release

The Digest’s 2026 Multi-Slide Guide to Bioproduct Quality Release

August 20, 2026 |

Commercial-scale production outpaces traditional laboratory-style, end-of-batch quality control capacity by orders of magnitude, turning quality release into a severe operational bottleneck. Upstream debottlenecking simply increases warehouse queues and ties up crucial working capital in quality-hold inventory. The remedy is transitioning to real-time release testing supported by scientific process understanding, validated in-line measurements, and electronic batch […]

Read More

100 Hottest Projects in the Advanced Bioeconomy 2026

100 Hottest Projects in the Advanced Bioeconomy 2026

August 20, 2026 |

Today, The Daily Digest is releasing The Digest’s 100 Hottest Projects in the Bioeconomy— 2026 Edition, our annual benchmark profiling and ranking the world’s leading commercial-scale bioeconomy assets. This year’s rankings focuses on execution—curating benchmark facilities that have achieved Final Investment Decisions (FID), financial close, or construction milestones across 2025–2026. Spanning more than 15 countries across North […]

Read More

The Digest’s 2026 Multi-Slide Guide to Industrial GMP Discipline

The Digest’s 2026 Multi-Slide Guide to Industrial GMP Discipline

August 19, 2026 |

For bioeconomy operators, managing mixed-grade facilities that produce both pharmaceutical-grade and industrial-grade products is a critical challenge. Successful segregation of airflows, personnel, and materials must be engineered at the design stage; post-construction procedural retrofits are costly and often generate severe audit findings. A clean inspection record acts as a valuable commercial asset, shortening customer qualification […]

Read More

The Digest’s 2026 Multi-Slide Guide to Strain Stability

The Digest’s 2026 Multi-Slide Guide to Strain Stability

August 18, 2026 |

Engineered strains frequently experience genetic drift under industrial conditions, leading to gradual, mid-life performance declines that remain invisible to standard month-to-month management reviews. This slow decay erodes cumulative titer and yield, threatening the long-term financial viability of assets and jeopardizing offtake or debt agreements. To de-risk commercial scale-up, operators must move beyond short-term milestones and […]

Read More

Next Page »
}